LAB icon

Standard BioTools

144 hedge funds and large institutions have $480M invested in Standard BioTools in 2024 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 39 increasing their positions, 35 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding:

18.23% less ownership

Funds ownership: 91.46%73.23% (-18%)

33% less capital invested

Capital invested by funds: $719M → $480M (-$239M)

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
144
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.26M
Puts
$110K
Net Calls
Net Calls Change

Top Buyers

1 +$28.9M
2 +$9.41M
3 +$7.24M
4
State Street
State Street
Massachusetts
+$5.3M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$5.26M

Top Sellers

1 -$20M
2 -$14.4M
3 -$6.81M
4
Goldman Sachs
Goldman Sachs
New York
-$4.67M
5
PHP
Parkman Healthcare Partners
Connecticut
-$4.53M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$113M
2
$104M
3
$38.5M
4
$28.3M
5
$22.9M
6
$22.4M
7
$18.8M
8
$18.7M
9
$12M
10
$11.6M
11
$11M
12
$7.68M
13
$7.32M
14
$5.33M
15
$5.05M
16
$3.33M
17
$2.86M
18
$2.18M
19
$1.78M
20
$1.77M
21
$1.77M
22
$1.74M
23
$1.74M
24
$1.73M
25
$1.68M